Cochrane Funding Program 2026

Cochrane is an international, independent, not-for-profit organisation that aims to promote evidence-based practice in service provision and clinical healthcare. Cochrane systematic reviews are a key element in improving the quality and accessibility of the evidence to support healthcare decision making. The Australian Government has announced a total of $6,476,822 (GST exclusive) to support Cochrane activities in Australia over four years (from 1 July 2026 to 30 June 2030). This funding will be administered by the National Health and Medical Research Council (NHMRC). The objectives of this funding program are to: - Support Australian Cochrane review production and evidence synthesis to inform healthcare decision making. - Ensure that resources are allocated to specific, measurable activities that deliver high value outputs. For further information on the Cochrane Funding Program 2026, see the Cochrane Administered Funding Grant 2026-2030_grant opportunity guidelines. The activities that fall within this grant support NHMRC’s strategic priorities: in particular the translation of research into public policy, health systems and clinical practice, and the use of new tools and technologies to improve healthcare including artificial intelligence in health. These are aligned with the Australian Government’s commitment to evidence-based healthcare and focus on priorities for national policy and decision making.